ng-nitroarginine methyl ester and Cardiotoxicity

ng-nitroarginine methyl ester has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, JS; Chen, JW; Huang, PH; Huang, WP; Lin, SJ; Yin, WH	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Cardiotoxicity

Article	Year
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway. Scientific reports, 2021, 01-13, Volume: 11, Issue:1 Topics: Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Endothelial Progenitor Cells; Endothelium; Fenofibrate; Heart Failure; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A	2021

Article

Year

Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway.

Scientific reports, 2021, 01-13, Volume: 11, Issue:1

Topics: Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Endothelial Progenitor Cells; Endothelium; Fenofibrate; Heart Failure; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A

2021